 | • レポートコード：MRC2-11QY04302 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は肺炎診断のグローバル市場について調査・分析したレポートです。種類別（連鎖球菌ベース、レジオネラベース、クラミドフィラベース、ウイルス性肺炎ベース、マイコプラズマ肺炎ベース）市場規模、用途別（病院、診療所、診断センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別肺炎診断の競争状況、市場シェア ・世界の肺炎診断市場：種類別市場規模 2015年-2020年（連鎖球菌ベース、レジオネラベース、クラミドフィラベース、ウイルス性肺炎ベース、マイコプラズマ肺炎ベース） ・世界の肺炎診断市場：種類別市場規模予測 2021年-2026年（連鎖球菌ベース、レジオネラベース、クラミドフィラベース、ウイルス性肺炎ベース、マイコプラズマ肺炎ベース） ・世界の肺炎診断市場：用途別市場規模 2015年-2020年（病院、診療所、診断センター、その他） ・世界の肺炎診断市場：用途別市場規模予測 2021年-2026年（病院、診療所、診断センター、その他） ・北米の肺炎診断市場分析：米国、カナダ ・ヨーロッパの肺炎診断市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの肺炎診断市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の肺炎診断市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの肺炎診断市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott、Glaxo Smith Kline、Affymetrix、Becton Dickinson、BioMerieux、Cepheid、Diamedix/Erba ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Pneumonia Diagnostic Market
The global Pneumonia Diagnostic market size is projected to reach US$ 471.4 million by 2026, from US$ 446.3 million in 2020, at a CAGR of 5.1%% during 2021-2026.
Global Pneumonia Diagnostic Scope and Market Size
Pneumonia Diagnostic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pneumonia Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott
Glaxo Smith Kline
Affymetrix
Becton Dickinson
BioMerieux
Cepheid
Diamedix/Erba
…
Market segment by Type, the product can be split into
Streptococcus-based
Legionella-based
Chlamydophila-based
Viral Pneumonia-based
Mycoplasma Pneumonia-based
Market segment by Application, split into
Hospitals
Clinics
Diagnostic Centres
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pneumonia Diagnostic Revenue
1.4 Market by Type
1.4.1 Global Pneumonia Diagnostic Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Streptococcus-based
1.4.3 Legionella-based
1.4.4 Chlamydophila-based
1.4.5 Viral Pneumonia-based
1.4.6 Mycoplasma Pneumonia-based
1.5 Market by Application
1.5.1 Global Pneumonia Diagnostic Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Diagnostic Centres
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Pneumonia Diagnostic Market Perspective (2015-2026)
2.2 Global Pneumonia Diagnostic Growth Trends by Regions
2.2.1 Pneumonia Diagnostic Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Pneumonia Diagnostic Historic Market Share by Regions (2015-2020)
2.2.3 Pneumonia Diagnostic Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Pneumonia Diagnostic Market Growth Strategy
2.3.6 Primary Interviews with Key Pneumonia Diagnostic Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Pneumonia Diagnostic Players by Market Size
3.1.1 Global Top Pneumonia Diagnostic Players by Revenue (2015-2020)
3.1.2 Global Pneumonia Diagnostic Revenue Market Share by Players (2015-2020)
3.1.3 Global Pneumonia Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pneumonia Diagnostic Market Concentration Ratio
3.2.1 Global Pneumonia Diagnostic Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Pneumonia Diagnostic Revenue in 2019
3.3 Pneumonia Diagnostic Key Players Head office and Area Served
3.4 Key Players Pneumonia Diagnostic Product Solution and Service
3.5 Date of Enter into Pneumonia Diagnostic Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Pneumonia Diagnostic Historic Market Size by Type (2015-2020)
4.2 Global Pneumonia Diagnostic Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Pneumonia Diagnostic Market Size by Application (2015-2020)
5.2 Global Pneumonia Diagnostic Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Pneumonia Diagnostic Market Size (2015-2020)
6.2 Pneumonia Diagnostic Key Players in North America (2019-2020)
6.3 North America Pneumonia Diagnostic Market Size by Type (2015-2020)
6.4 North America Pneumonia Diagnostic Market Size by Application (2015-2020)
7 Europe
7.1 Europe Pneumonia Diagnostic Market Size (2015-2020)
7.2 Pneumonia Diagnostic Key Players in Europe (2019-2020)
7.3 Europe Pneumonia Diagnostic Market Size by Type (2015-2020)
7.4 Europe Pneumonia Diagnostic Market Size by Application (2015-2020)
8 China
8.1 China Pneumonia Diagnostic Market Size (2015-2020)
8.2 Pneumonia Diagnostic Key Players in China (2019-2020)
8.3 China Pneumonia Diagnostic Market Size by Type (2015-2020)
8.4 China Pneumonia Diagnostic Market Size by Application (2015-2020)
9 Japan
9.1 Japan Pneumonia Diagnostic Market Size (2015-2020)
9.2 Pneumonia Diagnostic Key Players in Japan (2019-2020)
9.3 Japan Pneumonia Diagnostic Market Size by Type (2015-2020)
9.4 Japan Pneumonia Diagnostic Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Pneumonia Diagnostic Market Size (2015-2020)
10.2 Pneumonia Diagnostic Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pneumonia Diagnostic Market Size by Type (2015-2020)
10.4 Southeast Asia Pneumonia Diagnostic Market Size by Application (2015-2020)
11 India
11.1 India Pneumonia Diagnostic Market Size (2015-2020)
11.2 Pneumonia Diagnostic Key Players in India (2019-2020)
11.3 India Pneumonia Diagnostic Market Size by Type (2015-2020)
11.4 India Pneumonia Diagnostic Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Pneumonia Diagnostic Market Size (2015-2020)
12.2 Pneumonia Diagnostic Key Players in Central & South America (2019-2020)
12.3 Central & South America Pneumonia Diagnostic Market Size by Type (2015-2020)
12.4 Central & South America Pneumonia Diagnostic Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott
13.1.1 Abbott Company Details
13.1.2 Abbott Business Overview
13.1.3 Abbott Pneumonia Diagnostic Introduction
13.1.4 Abbott Revenue in Pneumonia Diagnostic Business (2015-2020))
13.1.5 Abbott Recent Development
13.2 Glaxo Smith Kline
13.2.1 Glaxo Smith Kline Company Details
13.2.2 Glaxo Smith Kline Business Overview
13.2.3 Glaxo Smith Kline Pneumonia Diagnostic Introduction
13.2.4 Glaxo Smith Kline Revenue in Pneumonia Diagnostic Business (2015-2020)
13.2.5 Glaxo Smith Kline Recent Development
13.3 Affymetrix
13.3.1 Affymetrix Company Details
13.3.2 Affymetrix Business Overview
13.3.3 Affymetrix Pneumonia Diagnostic Introduction
13.3.4 Affymetrix Revenue in Pneumonia Diagnostic Business (2015-2020)
13.3.5 Affymetrix Recent Development
13.4 Becton Dickinson
13.4.1 Becton Dickinson Company Details
13.4.2 Becton Dickinson Business Overview
13.4.3 Becton Dickinson Pneumonia Diagnostic Introduction
13.4.4 Becton Dickinson Revenue in Pneumonia Diagnostic Business (2015-2020)
13.4.5 Becton Dickinson Recent Development
13.5 BioMerieux
13.5.1 BioMerieux Company Details
13.5.2 BioMerieux Business Overview
13.5.3 BioMerieux Pneumonia Diagnostic Introduction
13.5.4 BioMerieux Revenue in Pneumonia Diagnostic Business (2015-2020)
13.5.5 BioMerieux Recent Development
13.6 Cepheid
13.6.1 Cepheid Company Details
13.6.2 Cepheid Business Overview
13.6.3 Cepheid Pneumonia Diagnostic Introduction
13.6.4 Cepheid Revenue in Pneumonia Diagnostic Business (2015-2020)
13.6.5 Cepheid Recent Development
13.7 Diamedix/Erba
13.7.1 Diamedix/Erba Company Details
13.7.2 Diamedix/Erba Business Overview
13.7.3 Diamedix/Erba Pneumonia Diagnostic Introduction
13.7.4 Diamedix/Erba Revenue in Pneumonia Diagnostic Business (2015-2020)
13.7.5 Diamedix/Erba Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Pneumonia Diagnostic Key Market Segments
Table 2. Key Players Covered: Ranking by Pneumonia Diagnostic Revenue
Table 3. Ranking of Global Top Pneumonia Diagnostic Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pneumonia Diagnostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Streptococcus-based
Table 6. Key Players of Legionella-based
Table 7. Key Players of Chlamydophila-based
Table 8. Key Players of Viral Pneumonia-based
Table 9. Key Players of Mycoplasma Pneumonia-based
Table 10. Global Pneumonia Diagnostic Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Pneumonia Diagnostic Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Pneumonia Diagnostic Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Pneumonia Diagnostic Market Share by Regions (2015-2020)
Table 14. Global Pneumonia Diagnostic Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Pneumonia Diagnostic Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Pneumonia Diagnostic Market Growth Strategy
Table 20. Main Points Interviewed from Key Pneumonia Diagnostic Players
Table 21. Global Pneumonia Diagnostic Revenue by Players (2015-2020) (Million US$)
Table 22. Global Pneumonia Diagnostic Market Share by Players (2015-2020)
Table 23. Global Top Pneumonia Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumonia Diagnostic as of 2019)
Table 24. Global Pneumonia Diagnostic by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Pneumonia Diagnostic Product Solution and Service
Table 27. Date of Enter into Pneumonia Diagnostic Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Pneumonia Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 30. Global Pneumonia Diagnostic Market Size Share by Type (2015-2020)
Table 31. Global Pneumonia Diagnostic Revenue Market Share by Type (2021-2026)
Table 32. Global Pneumonia Diagnostic Market Size Share by Application (2015-2020)
Table 33. Global Pneumonia Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 34. Global Pneumonia Diagnostic Market Size Share by Application (2021-2026)
Table 35. North America Key Players Pneumonia Diagnostic Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Pneumonia Diagnostic Market Share (2019-2020)
Table 37. North America Pneumonia Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 38. North America Pneumonia Diagnostic Market Share by Type (2015-2020)
Table 39. North America Pneumonia Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 40. North America Pneumonia Diagnostic Market Share by Application (2015-2020)
Table 41. Europe Key Players Pneumonia Diagnostic Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Pneumonia Diagnostic Market Share (2019-2020)
Table 43. Europe Pneumonia Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Pneumonia Diagnostic Market Share by Type (2015-2020)
Table 45. Europe Pneumonia Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Pneumonia Diagnostic Market Share by Application (2015-2020)
Table 47. China Key Players Pneumonia Diagnostic Revenue (2019-2020) (Million US$)
Table 48. China Key Players Pneumonia Diagnostic Market Share (2019-2020)
Table 49. China Pneumonia Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 50. China Pneumonia Diagnostic Market Share by Type (2015-2020)
Table 51. China Pneumonia Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 52. China Pneumonia Diagnostic Market Share by Application (2015-2020)
Table 53. Japan Key Players Pneumonia Diagnostic Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Pneumonia Diagnostic Market Share (2019-2020)
Table 55. Japan Pneumonia Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Pneumonia Diagnostic Market Share by Type (2015-2020)
Table 57. Japan Pneumonia Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Pneumonia Diagnostic Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Pneumonia Diagnostic Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Pneumonia Diagnostic Market Share (2019-2020)
Table 61. Southeast Asia Pneumonia Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Pneumonia Diagnostic Market Share by Type (2015-2020)
Table 63. Southeast Asia Pneumonia Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Pneumonia Diagnostic Market Share by Application (2015-2020)
Table 65. India Key Players Pneumonia Diagnostic Revenue (2019-2020) (Million US$)
Table 66. India Key Players Pneumonia Diagnostic Market Share (2019-2020)
Table 67. India Pneumonia Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 68. India Pneumonia Diagnostic Market Share by Type (2015-2020)
Table 69. India Pneumonia Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 70. India Pneumonia Diagnostic Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Pneumonia Diagnostic Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Pneumonia Diagnostic Market Share (2019-2020)
Table 73. Central & South America Pneumonia Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Pneumonia Diagnostic Market Share by Type (2015-2020)
Table 75. Central & South America Pneumonia Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Pneumonia Diagnostic Market Share by Application (2015-2020)
Table 77. Abbott Company Details
Table 78. Abbott Business Overview
Table 79. Abbott Product
Table 80. Abbott Revenue in Pneumonia Diagnostic Business (2015-2020) (Million US$)
Table 81. Abbott Recent Development
Table 82. Glaxo Smith Kline Company Details
Table 83. Glaxo Smith Kline Business Overview
Table 84. Glaxo Smith Kline Product
Table 85. Glaxo Smith Kline Revenue in Pneumonia Diagnostic Business (2015-2020) (Million US$)
Table 86. Glaxo Smith Kline Recent Development
Table 87. Affymetrix Company Details
Table 88. Affymetrix Business Overview
Table 89. Affymetrix Product
Table 90. Affymetrix Revenue in Pneumonia Diagnostic Business (2015-2020) (Million US$)
Table 91. Affymetrix Recent Development
Table 92. Becton Dickinson Company Details
Table 93. Becton Dickinson Business Overview
Table 94. Becton Dickinson Product
Table 95. Becton Dickinson Revenue in Pneumonia Diagnostic Business (2015-2020) (Million US$)
Table 96. Becton Dickinson Recent Development
Table 97. BioMerieux Company Details
Table 98. BioMerieux Business Overview
Table 99. BioMerieux Product
Table 100. BioMerieux Revenue in Pneumonia Diagnostic Business (2015-2020) (Million US$)
Table 101. BioMerieux Recent Development
Table 102. Cepheid Company Details
Table 103. Cepheid Business Overview
Table 104. Cepheid Product
Table 105. Cepheid Revenue in Pneumonia Diagnostic Business (2015-2020) (Million US$)
Table 106. Cepheid Recent Development
Table 107. Diamedix/Erba Company Details
Table 108. Diamedix/Erba Business Overview
Table 109. Diamedix/Erba Product
Table 110. Diamedix/Erba Revenue in Pneumonia Diagnostic Business (2015-2020) (Million US$)
Table 111. Diamedix/Erba Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pneumonia Diagnostic Market Share by Type: 2020 VS 2026
Figure 2. Streptococcus-based Features
Figure 3. Legionella-based Features
Figure 4. Chlamydophila-based Features
Figure 5. Viral Pneumonia-based Features
Figure 6. Mycoplasma Pneumonia-based Features
Figure 7. Global Pneumonia Diagnostic Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Diagnostic Centres Case Studies
Figure 11. Other Case Studies
Figure 12. Pneumonia Diagnostic Report Years Considered
Figure 13. Global Pneumonia Diagnostic Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Pneumonia Diagnostic Market Share by Regions: 2020 VS 2026
Figure 15. Global Pneumonia Diagnostic Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Pneumonia Diagnostic Market Share by Players in 2019
Figure 18. Global Top Pneumonia Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumonia Diagnostic as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Pneumonia Diagnostic Revenue in 2019
Figure 20. North America Pneumonia Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Pneumonia Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Pneumonia Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Pneumonia Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Pneumonia Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Pneumonia Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Pneumonia Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
肺炎の世界市場（～2026年） Pneumonia is referred to as inflammatory, diseased condition of the lungs, which affects the alveoli of the lungs. Symptoms of pneumonia include chest pain, dry cough, trouble in breathing, and fever. Acquired pneumonia and health care-associated pneumonia are two types of pneumonia. Pneumonia affec…- 人工呼吸器関連肺炎（VAP）の世界市場（～2026年） Market Analysis and Insights: Global Ventilator Associated Pneumonia (VAP) Market The global Ventilator Associated Pneumonia (VAP) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Ventilator Associated Pneumonia (VAP) S…
- 院内肺炎予防の世界市場（～2026年） HAP is defined as a lower respiratory infection, which does not incubate at the time of hospital admission but presents clinically 2 or more days after hospitalization.Incidence of HAP is more prevalent in the medical and surgical Intensive Care Units, and results in additional cost to the healthcar…
- 肺炎治療薬の世界市場（～2026年） Pneumonia is a respiratory disease characterized by inflammation of air sacs in lungs due to bacterial or viral infection. The emergence of advanced diagnostic techniques to be one of the primary factors fueling the growth of the pneumonia therapeutics market in the coming years. Market Analysis and…
- 市中肺炎（CAP）の世界市場（～2026年） Community-acquired pneumonia (CAP) refers to pneumonia (any of several lung diseases) contracted by a person with little contact with the healthcare system. The market of CAP treatment and diagnosis in further segmented with respect to major geographies of North America, Europe, Asia-Pacific, and La…